Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study

Okosieme, Onyebuchi E., Taylor, Peter N. ORCID: https://orcid.org/0000-0002-3436-422X, Evans, Carol, Thayer, Dan, Chai, Aaron, Khan, Ishrat, Draman, Mohd S., Tennant, Brian, Geen, John, Sayers, Adrian, French, Robert ORCID: https://orcid.org/0000-0002-9064-9721, Lazarus, John H., Premawardhana, Lakdasa D. and Dayan, Colin M. ORCID: https://orcid.org/0000-0002-6557-3462 2019. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study. Lancet Diabetes and Endocrinology 7 (4) , pp. 278-287. 10.1016/S2213-8587(19)30059-2

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview

Abstract

Graves' disease is routinely treated with antithyroid drugs, radioiodine, or surgery, but whether the choice of initial therapy influences long-term outcomes is uncertain. We evaluated cardiovascular morbidity and mortality according to the method and effectiveness of primary therapy in Graves' disease.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISSN:	2213-8587
Date of First Compliant Deposit:	21 March 2019
Date of Acceptance:	28 February 2019
Last Modified:	11 Oct 2024 20:26
URI:	https://orca.cardiff.ac.uk/id/eprint/120984

Citation Data

Cited 59 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item